SCHEMBL1974142

SCHEMBL1974142

CN1CCC(Oc2cccc(S(=O)(=O)n3ccc4ccc(Cl)cc43)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 12/20 0.56
CYP3A4 P08684 3/20 0.56
HTR1A P08908 1/20 0.47
DRD2 P14416 1/20 0.47
HTR2C P28335 1/20 0.46
FPR2 P25090 1/20 0.44
PROKR1 Q8TCW9 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
EPHX2 P34913 1/20 0.44
PPARG P37231 2/20 0.43
PPARD Q03181 2/20 0.43
PPARA Q07869 2/20 0.43
CPT2 P23786 1/20 0.41
CPT1A P50416 1/20 0.41
CPT1B Q92523 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1975488 0.88 HTR6 (0.51) HTR6CYP3A4HTR1ADRD2MEN1
SCHEMBL1972934 0.83 HTR6 (0.59) HTR6CYP3A4HTR1ADRD2HTR2C
SCHEMBL1975364 0.82 HTR6 (0.68) HTR6CYP3A4DRD2HTR2C
SCHEMBL1971519 0.82 HTR6 (0.55) HTR6CYP3A4
SCHEMBL1971888 0.82 HTR6 (0.60) HTR6CYP3A4MEN1KMT2APPARG
SCHEMBL1975058 0.82 HTR6 (0.57) HTR6CYP3A4HTR1ADRD2HTR2C
SCHEMBL2268980 0.80 HTR6 (0.56) HTR6CYP3A4HTR1ADRD2HTR2C
SCHEMBL2231819 0.80 HTR6 (0.55) HTR6CYP3A4HTR1ADRD2MEN1
SCHEMBL3665364 0.79 HTR6 (0.52) HTR6CYP3A4HTR1ADRD2MEN1
SCHEMBL1973239 0.76 HTR6 (0.60) HTR6CYP3A4DRD2HTR2CFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003670-B2 Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-08-23 US disclosed
EP-2155674-B1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LTD (IN) 2011-06-22 EP disclosed
US-20100087484-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2010-04-08 US disclosed
EP-2155674-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS Suven Life Sciences Limited (IN) 2010-02-24 EP disclosed
WO-2008136017-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2008-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087484-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS HTR6, HTR5A, HTR1B HTR6 1/4885CYP3A4 478/4885HTR1A 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.